| Drug Type Small molecule drug | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism PGES inhibitors(Prostaglandin E synthase inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 2 | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC25H20ClF3N4O3 | 
| InChIKeyZPONWJXTHMDOSV-UHFFFAOYSA-N | 
| CAS Registry1422203-86-8 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Chronic pelvic pain syndrome | Phase 2 | Japan  | 01 Jun 2023 | |
| Chronic prostatitis | Phase 2 | Japan  | 01 Jun 2023 | |
| Endometriosis | Phase 2 | Japan  | 22 Apr 2022 | 





